67 related articles for article (PubMed ID: 16678893)
1. Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark.
Kristiansen IS; Gyrd-Hansen D; Nexøe J; Bo Nielsen J
Prev Med; 2006 Jul; 43(1):31-5. PubMed ID: 16678893
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
Tang CH; Liu JT; Chang CW; Chang WY
Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
[TBL] [Abstract][Full Text] [Related]
3. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.
Tang JL; Wang WZ; An JG; Hu YH; Cheng SH; Griffiths S
Int J Epidemiol; 2010 Feb; 39(1):244-54. PubMed ID: 19491141
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Fodor JG; Whitmore B; Leenen F; Larochelle P
CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
[TBL] [Abstract][Full Text] [Related]
5. Willingness to pay for public health care: a comparison of two approaches.
Olsen JA; Kidholm K; Donaldson C; Shackley P
Health Policy; 2004 Nov; 70(2):217-28. PubMed ID: 15364151
[TBL] [Abstract][Full Text] [Related]
6. Reducing population salt intake worldwide: from evidence to implementation.
He FJ; MacGregor GA
Prog Cardiovasc Dis; 2010; 52(5):363-82. PubMed ID: 20226955
[TBL] [Abstract][Full Text] [Related]
7. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
Pinto-Prades JL; Farreras V; de Bobadilla JF
Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
[TBL] [Abstract][Full Text] [Related]
8. Disentangling WTP per QALY data: different analytical approaches, different answers.
Gyrd-Hansen D; Kjaer T
Health Econ; 2012 Mar; 21(3):222-37. PubMed ID: 21254305
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
Murray CJ; Lauer JA; Hutubessy RC; Niessen L; Tomijima N; Rodgers A; Lawes CM; Evans DB
Lancet; 2003 Mar; 361(9359):717-25. PubMed ID: 12620735
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of interventions to reduce dietary salt intake.
Cobiac LJ; Vos T; Veerman JL
Heart; 2010 Dec; 96(23):1920-5. PubMed ID: 21041840
[TBL] [Abstract][Full Text] [Related]
11. Patient willingness to pay for preventive measures in primary care: a study of five GPs in a German community.
Wiesemann A; Mueller-Buehl U; Scheidt R; Boehme W; Scheuermann W
Soz Praventivmed; 2004; 49(4):254-60. PubMed ID: 15357527
[TBL] [Abstract][Full Text] [Related]
12. The citizen's preferences for financing public health care: a Danish survey.
Gyrd-Hansen D; Slothuus U
Int J Health Care Finance Econ; 2002 Mar; 2(1):25-36. PubMed ID: 14625906
[TBL] [Abstract][Full Text] [Related]
13. [An evaluation on effectiveness of worksite-based intervention for cardiovascular disease during 1974 - 1998 in capital iron and steel company of Beijing].
Wu XG; Gu DF; Wu YF; Yu XH; Wang SY; Wang N; Gao JM; Duan XF; Zhou BF; Liu LS
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):93-7. PubMed ID: 12839658
[TBL] [Abstract][Full Text] [Related]
14. Valuation of tobacco control policies by the public in North Carolina: comparing perceived benefit with projected cost of implementation.
Sanders AE; Slade GD; Ranney LM; Jones LK; Goldstein AO
N C Med J; 2012; 73(6):439-47. PubMed ID: 23617155
[TBL] [Abstract][Full Text] [Related]
15. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
Gyrd-Hansen D; Jensen ML; Kjaer T
Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
[TBL] [Abstract][Full Text] [Related]
16. Individual responsibility and health-risk behaviour: a contingent valuation study from the ex ante societal perspective.
van der Star SM; van den Berg B
Health Policy; 2011 Aug; 101(3):300-11. PubMed ID: 21168930
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for lung cancer treatment.
Lang HC
Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of work-site wellness programs for hypertension control, weight loss, and smoking cessation.
Erfurt JC; Foote A; Heirich MA
J Occup Med; 1991 Sep; 33(9):962-70. PubMed ID: 1744745
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for home- and community-based services for seniors in Florida.
Loh CP; Shapiro A
Home Health Care Serv Q; 2013; 32(1):17-34. PubMed ID: 23438507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
